Market Overview

Morning Market Losers

Related GLOW
US Stock Futures Down Ahead Of Earnings
Main Street Announces $9.2M Investment in Glowpoint
Related CYCC
Cyclacel Announces First Patient Dosed in IST of CDK Inhibitor Seliciclib in Cushing's Disease,
Cyclacel Pharmaceuticals Shares Surge After Q4 Results
Biotech Weekly: Reviewing The <1x Book Biotech Screen (Seeking Alpha)

Glowpoint (NYSE: GLOW) dropped 12.50% to $1.40. Glowpoint shares have dropped 25.93% over the past 52 weeks, while the S&P 500 index has gained 17.37% in the same period.

Cyclacel Pharmaceuticals (NASDAQ: CYCC) plummeted 10.56% to $4.24. Cyclacel Pharmaceuticals' trailing-twelve-month EPS is -$1.69.

L & L Energy (NASDAQ: LLEN) dropped 10.48% to $1.13. L & L Energy had $9.04 million in total cash for the recent quarter.

Ambient (NASDAQ: AMBT) dropped 9.66% to $2.62. Ambient's trailing-twelve-month ROE is -112.10%.

Posted-In: Morning Market LosersNews Movers & Shakers Intraday Update Markets


Related Articles (CYCC + AMBT)

Get Benzinga's Newsletters